Clinical Trials Logo

Corneal Diseases clinical trials

View clinical trials related to Corneal Diseases.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04734158 Active, not recruiting - Clinical trials for Cornea Epithelial Mapping

CORNEAL EPITHELIAL MAPPING IN DIABETICS

Start date: August 12, 2019
Phase:
Study type: Observational

The corneal epithelium is the outermost layer that covers the front of the eye; it not only functions as a barrier that blocks the passage of foreign material, but also plays an important role in maintaining high optical quality. The stem cells in the basal layer of the limbal epithelium hold a physiological significance in the renewal and metabolism of corneal epithelium, particularly under stressful situations.

NCT ID: NCT04668924 Active, not recruiting - Keratoconus Clinical Trials

Epi-on PiXL for the Treatment of Progressive Keratoconus.

Start date: March 20, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety and postoperative ocular discomfort by individually customized Photorefractive intrastromal crosslinking (PiXL) without epithelium debridement in high oxygen environment (Epi-on) for progressive Keratoconus.

NCT ID: NCT01464268 Active, not recruiting - Keratoconus Clinical Trials

Transepithelial Corneal Collagen Crosslinking for Keratoconus and Corneal Ectasia

Start date: November 2011
Phase: Phase 3
Study type: Interventional

Corneal collagen crosslinking (CXL) has been proposed as an effective method of reducing progression of both keratoconus and corneal ectasia after surgery, as well as possibly decreasing the steepness of the cornea in these pathologies. During previous studies of the CXL procedure, the surface epithelial cells have been removed. Transepithelial crosslinking in which the epithelium is not removed has been proposed to offer a number of advantages over traditional crosslinking including an increased safety profile by reducing the risk for infection as no epithelial barrier will be broken, faster visual recovery and improved patient comfort in the early postoperative healing period.

NCT ID: NCT01112072 Active, not recruiting - Keratoconus Clinical Trials

Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia

CXL
Start date: April 2010
Phase: Phase 3
Study type: Interventional

This study will determine the efficacy of corneal collagen crosslinking (CXL) combined with Intacs for the treatment of keratoconus and corneal ectasia. The goal of CXL is to decrease the progression of keratoconus, while Intacs has been shown to decrease corneal steepness in keratoconus. This study will attempt to determine the relative efficacy of the two procedures either performed at the same session versus CXL performed 3 months after Intacs.

NCT ID: NCT00343473 Active, not recruiting - Fuch's Dystrophy Clinical Trials

Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye

Start date: October 2005
Phase:
Study type: Observational

The purpose of this research is to evaluate the optical coherence tomography (OCT), to image diseases of the eye. OCT may be useful for the early diagnosis and monitoring of a variety of diseases involving the eye, such as Fuch's Dystrophy (type of eye disease) and retinal damage (eye diseases in the back of the eye) due to diabetes.